Keytruda RCC Approval/I-O – Toni Choueiri, MD, and Robert Figlin, MD, discuss the recent Keytruda approval in renal cell carcinoma (RCC) - a podcast by OBR Peer-Spectives

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Toni Choueiri, MD, Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute, discuss Keytruda’s approval in renal cell carcinoma (RCC).

Further episodes of OBR Peer-Spectives

Further podcasts by OBR Peer-Spectives

Website of OBR Peer-Spectives